Domperidone

Study	Exclusion reasons	Rmk	Reference
Brock-Utne, 1980	not relevant outcome	EXCLUDED: efficacy (no data on safety of fetus, neonate and/or parturiente).	Brock-Utne JG Anesthesiology 1980;52:321-3
Benevent, 2019	Studies without separate analysis of the considered drug/class from other drugs/class	EXCLUDED: Atropinic drugs analyzed as a whole without distinction between treatments.	Benevent Fundam Clin Pharmacol 2019; 33:314-326 10.1111/fcp.12428
Beau, 2016	Studies without separate analysis of the considered drug/class from other drugs/class	EXCLUDED: Atropinic drugs analyzed as a whole without distinction between treatments.	Beau Br J Clin Pharmacol 2016; 82:478-86 10.1111/bcp.12978
Banhidy, 2007	Studies without separate analysis of the considered drug/class from other drugs/class	EXCLUDED: analysis according to illness status, without distinction between treatments.	Banhidy Eur. J. Obstet. Gynecol. Reprod. Biol. 2007; 134:157-63 10.1016/j.ejogrb.2006.08.025
Bérard, 2019	pattern of exposure	EXCLUDED: Pattern of exposure. Pregnancy outcome (delivery, spontaneous or induced/plannedabortions) described according medication use as a whole.	Bérard PLoS ONE 2019; 14:e0219095 10.1371/journal.pone.0219095
Baraka, 2013	pattern of exposure	EXCLUDED: study on pattern of exposure without data on fetal/maternal/neonatal safety.	Baraka J. Matern. Fetal. Neonatal. Med. 2013; 26:900-7 10.3109/14767058.2013.765843